Artisan Sold Insulet (PODD) Due to Competition Concerns
Artisan Partners decided to divest from Insulet Corporation (NASDAQ:PODD) in its second-quarter 2026 investor letter, citing growing competition in the insulin pump market. Insulet Corporation is a leading American medical device company known for its Omnipod insulin delivery system, which offers a tubeless automated insulin delivery system.
The company benefits from strong patient adoption, expanding penetration in the type 2 diabetes market, and its pharmacy-based distribution model. The fund's investment in Insulet Corporation resulted in a strong performance in Q2 2026, with the fund returning 17.86% compared to the 14.55% gain for the Russell Midcap® Growth Index.
The fund's decision to sell its stake in Insulet Corporation will be allocated to higher conviction opportunities.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.